| P2093 | author name string | P G Georgiev | |
| | O G Maksimenko | |
| | Yu M Khodarovich | |
| | A V Deykin | |
| P2860 | cites work | Distal control of the pig whey acidic protein (WAP) locus in transgenic mice | Q80782779 |
| | Purification and characterization of a recombinant version of human alpha-fetoprotein expressed in the milk of transgenic goats | Q81038309 |
| | Production of recombinant albumin by a herd of cloned transgenic cattle | Q82713021 |
| | Production of human lactoferrin in animal milk | Q83502637 |
| | The state of health and the reproductive potential of transgenic mice secreting recombinant human lactoferrin in milk | Q84686010 |
| | Transmission of prions | Q24540228 |
| | Recombinant human butyrylcholinesterase from milk of transgenic animals to protect against organophosphate poisoning | Q24683895 |
| | Germline transgenic pigs by Sleeping Beauty transposition in porcine zygotes and targeted integration in the pig genome | Q27324003 |
| | The protein CTCF is required for the enhancer blocking activity of vertebrate insulators | Q28142800 |
| | Pigs expressing salivary phytase produce low-phosphorus manure | Q28209995 |
| | Viable offspring derived from fetal and adult mammalian cells | Q28304072 |
| | Cattle mammary bioreactor generated by a novel procedure of transgenic cloning for large-scale production of functional human lactoferrin | Q28473868 |
| | Production of cattle lacking prion protein. | Q30492928 |
| | Species-specific variation in glycosylation of IgG: evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics | Q30857760 |
| | N- and O-glycans of recombinant human C1 inhibitor expressed in the milk of transgenic rabbits | Q31003775 |
| | Lysostaphin expression in mammary glands confers protection against staphylococcal infection in transgenic mice | Q31793558 |
| | VEZF1 elements mediate protection from DNA methylation | Q33523011 |
| | Biopharmaceutical production in transgenic livestock | Q33719380 |
| | Transgenic mice secreting coronavirus neutralizing antibodies into the milk | Q33782648 |
| | Transgenic milk as a method for the production of recombinant antibodies | Q33825189 |
| | Is there a risk from not using GE animals? | Q33833888 |
| | Production of transgenic mice by random recombination of targeted genes in female germline stem cells. | Q34154413 |
| | Cloned transgenic cattle produce milk with higher levels of beta-casein and kappa-casein | Q34172919 |
| | The current state of GMO governance: are we ready for GM animals? | Q34256621 |
| | Generating transgenic mice from bacterial artificial chromosomes: transgenesis efficiency, integration and expression outcomes. | Q34468652 |
| | Preparation of recombinant proteins in milk to improve human and animal health. | Q34581876 |
| | Transgenic alteration of sow milk to improve piglet growth and health. | Q34617188 |
| | Genome-wide prediction of matrix attachment regions that increase gene expression in mammalian cells | Q34659480 |
| | Production of pharmaceutical proteins by transgenic animals | Q34744705 |
| | Expression and characterization of bioactive recombinant human alpha-lactalbumin in the milk of transgenic cloned cows. | Q34889966 |
| | Antibody manufacture in transgenic animals and comparisons with other systems | Q35026023 |
| | Relevance of BAC transgene copy number in mice: transgene copy number variation across multiple transgenic lines and correlations with transgene integrity and expression | Q35031058 |
| | Making recombinant proteins in animals--different systems, different applications. | Q35209242 |
| | Mammary expression of new genes to combat mastitis | Q35682256 |
| | Prospects and implications of using chromatin insulators in gene therapy and transgenesis | Q35819847 |
| | Use of the chicken lysozyme 5' matrix attachment region to generate high producer CHO cell lines. | Q50768570 |
| | Production of recombinant human lysozyme in the milk of transgenic pigs. | Q51559850 |
| | Adenoviral vector mediates high expression levels of human growth hormone in the milk of mice and goats. | Q51604726 |
| | Expression of active recombinant human lactoferrin in the milk of transgenic goats. | Q51725485 |
| | A mWAP-hLF hybrid gene locus gave extremely high level expression of human lactoferrin in the milk of transgenic mice. | Q51819442 |
| | Detection of endoplasmic reticulum stress markers and production enhancement treatments in transgenic goats expressing recombinant human butyrylcholinesterase. | Q52608297 |
| | High level expression of bioactive recombinant human growth hormone in the milk of a cloned transgenic cow. | Q53767961 |
| | Alteration of the quality of milk by expression of sheep β-lactoglobulin in transgenic mice | Q59086278 |
| | Tissue-specific and expression of porcine growth hormone gene in BAC transgenic mice | Q64463720 |
| | Production of the mouse whey acidic protein in transgenic pigs during lactation | Q67706678 |
| | Casein genes and genetic engineering of the caseins | Q70139515 |
| | Induction of human tissue plasminogen activator in the mammary gland of transgenic goats | Q72273389 |
| | Expression of human lactoferrin in milk of transgenic mice | Q72456336 |
| | Expression of active human blood clotting factor VIII in mammary gland of transgenic rabbits | Q73011515 |
| | Production of biologically active human granulocyte colony stimulating factor in the milk of transgenic goat | Q73079768 |
| | Expression of bovine beta-lactoglobulin/human erythropoietin fusion protein in the milk of transgenic mice and rabbits | Q73341007 |
| | Production of active anti-CD6 mouse/human chimeric antibodies in the milk of transgenic mice | Q73887021 |
| | Chicken beta-globin 5'HS4 insulators function to reduce variability in transgenic founder mice | Q73983972 |
| | The potential benefits of insulators on heterologous constructs in transgenic animals | Q75232573 |
| | Production of recombinant antibodies in the milk of transgenic animals | Q77624476 |
| | Transgenic animal bioreactors in biotechnology and production of blood proteins | Q77798567 |
| | High level expression of a functional human/mouse chimeric anti-CD20 monoclonal antibody in milk of transgenic mice | Q80467782 |
| | Analysis of the N-glycans of recombinant human Factor IX purified from transgenic pig milk | Q35835707 |
| | Transgenic animals in medicine: integration and expression of foreign genes, theoretical and applied aspects | Q35929035 |
| | Characterization of the chicken beta-globin insulator | Q35956059 |
| | Employing epigenetics to augment the expression of therapeutic proteins in mammalian cells | Q36388110 |
| | Genetic modifications of pigs for medicine and agriculture. | Q36466394 |
| | A generic intron increases gene expression in transgenic mice | Q36695893 |
| | Functional dissection of the mouse tyrosinase locus control region identifies a new putative boundary activity | Q37368665 |
| | Lactogenic hormonal induction of long distance interactions between beta-casein gene regulatory elements | Q37371658 |
| | Increasing the sialylation of therapeutic glycoproteins: the potential of the sialic acid biosynthetic pathway | Q37387167 |
| | Production of recombinant proteins by microbes and higher organisms | Q37509309 |
| | Animal-derived pharmaceutical proteins. | Q37547045 |
| | Expression systems for therapeutic glycoprotein production. | Q37627411 |
| | Recent advances in large-scale production of monoclonal antibodies and related proteins | Q37715488 |
| | Engineering mammalian cells in bioprocessing - current achievements and future perspectives | Q37730868 |
| | Recombinant plasma proteins | Q37822845 |
| | Advances in farm animal transgenesis. | Q37878026 |
| | CTCF: insights into insulator function during development | Q37987091 |
| | The use of UCOE vectors in combination with a preadapted serum free, suspension cell line allows for rapid production of large quantities of protein | Q39918311 |
| | Functional recombinant human anti-HAV antibody expressed in milk of transgenic mice | Q40011772 |
| | High-level expression of human lactoferrin in the milk of goats by using replication-defective adenoviral vectors. | Q40185831 |
| | Transgenic mice can express mutant human coagulation factor IX with higher level of clotting activity | Q40222400 |
| | The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity | Q40690773 |
| | Recombinant protein production in transgenic animals | Q41238612 |
| | Toward altering milk composition by genetic manipulation: current status and challenges | Q41602609 |
| | Targeting expression to the mammary gland: intronic sequences can enhance the efficiency of gene expression in transgenic mice | Q41653965 |
| | Recent Advances in Application of Male Germ Cell Transplantation in Farm Animals | Q41843370 |
| | Chromatin Boundaries, Insulators, and Long-Range Interactions in the Nucleus | Q42837625 |
| | Chromosome integration of BAC (bacterial artificial chromosome): evidence of multiple rearrangements | Q43690878 |
| | Genetically enhanced cows resist intramammary Staphylococcus aureus infection | Q44213530 |
| | A 3,387 bp 5'-flanking sequence of the goat alpha-S1-casein gene provides correct tissue-specific expression of human granulocyte colony-stimulating factor (hG-CSF) in the mammary gland of transgenic mice. | Q44357425 |
| | Phenotypic and genotypic stability of multiple lines of transgenic pigs expressing recombinant human protein C. | Q45104933 |
| | Recruitment of histone modifications by USF proteins at a vertebrate barrier element | Q45138460 |
| | Large scale production of recombinant human lactoferrin in the milk of transgenic cows | Q45231378 |
| | Engineering passive immunity in transgenic mice secreting virus-neutralizing antibodies in milk | Q45756684 |
| | Lysozyme transgenic goats' milk influences gastrointestinal morphology in young pigs. | Q45933060 |
| | Human lysozyme expressed in the mammary gland of transgenic dairy goats can inhibit the growth of bacteria that cause mastitis and the cold-spoilage of milk. | Q46027534 |
| | Expression of full-length human pro-urokinase in mammary glands of transgenic mice. | Q46035661 |
| | Transgenic salmon: a final leap to the grocery shelf? | Q46395760 |
| | Production and processing of milk from transgenic goats expressing human lysozyme in the mammary gland | Q46523142 |
| | Expression of human lysozyme mRNA in the mammary gland of transgenic mice | Q46666986 |
| | High expression level of recombinant human erythropoietin in the milk of non-transgenic goats. | Q46842938 |
| | Transgenically produced human antithrombin: structural and functional comparison to human plasma-derived antithrombin. | Q48004775 |
| | Identification of anti-repressor elements that confer high and stable protein production in mammalian cells | Q48252074 |
| | Expression of recombinant human factor VIII in milk of several generations of transgenic rabbits | Q48292669 |
| | Expression of human growth hormone-releasing factor in transgenic mice results in increased somatic growth. | Q48488820 |
| | The insulator effect of the 5'HS4 region from the beta-globin chicken locus on the rabbit WAP gene promoter activity in transgenic mice. | Q50682512 |
| P433 | issue | 1 | |
| P921 | main subject | biotechnology | Q7108 |
| P304 | page(s) | 33-46 | |
| P577 | publication date | 2013-01-01 | |
| P1433 | published in | Acta Naturae | Q27723435 |
| P1476 | title | Use of transgenic animals in biotechnology: prospects and problems | |
| P478 | volume | 5 | |